Nathan L. Mata

Insider

Chief Scientific Officer

Trades at: BLTE

30D 90D 1Y

Net shares · 90d

-16.7K

0 buy · 16.7K sell

Net value · 90d

-$2.7M

$0 in · $2.7M out

Sentiment · 90d

Net selling

0% buying · 100% selling

Open-market trades · 90d

103

0 buy · 16.7K sell

Trading track record · all companies

Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.

Transactions · 90d

Open-market Buys Sells All types

BLTE Sell·S
May 7, 26

Chief Scientific Officer · 10b5-1

$102.0K

666 sh · $153.21 avg · 4 lots

Own -100%
BLTE Sell·S
May 6, 26

Chief Scientific Officer · 10b5-1

$153.8K

1.0K sh · $153.84 avg · 6 lots

Own -60%
BLTE Sell·S
May 5, 26

Chief Scientific Officer · 10b5-1

$155.5K

1.0K sh · $155.50 avg · 6 lots

Own -38%
BLTE Sell·S
May 4, 26

Chief Scientific Officer · 10b5-1

$155.6K

1.0K sh · $155.64 avg · 5 lots

Own -27%
BLTE Sell·S
May 1, 26

Chief Scientific Officer · 10b5-1

$155.8K

1.0K sh · $155.78 avg · 8 lots

Own -21%
BLTE Sell·S
Apr 30, 26

Chief Scientific Officer · 10b5-1

$157.0K

1.0K sh · $156.97 avg · 4 lots

Own -18%
BLTE Sell·S
Apr 29, 26

Chief Scientific Officer · 10b5-1

$155.8K

1.0K sh · $155.82 avg · 5 lots

Own -15%
BLTE Sell·S
Apr 28, 26

Chief Scientific Officer · 10b5-1

$159.2K

1.0K sh · $159.16 avg · 9 lots

Own -13%
BLTE Sell·S
Apr 27, 26

Chief Scientific Officer · 10b5-1

$162.6K

1.0K sh · $162.64 avg · 5 lots

Own -12%
BLTE Sell·S
Apr 24, 26

Chief Scientific Officer · 10b5-1

$159.6K

1.0K sh · $159.56 avg · 6 lots

Own -10%
BLTE Sell·S
Apr 23, 26

Chief Scientific Officer · 10b5-1

$166.3K

1.0K sh · $166.28 avg · 6 lots

Own -9%
BLTE Sell·S
Apr 22, 26

Chief Scientific Officer · 10b5-1

$170.4K

1.0K sh · $170.38 avg · 9 lots

Own -9%
BLTE Sell·S
Apr 21, 26

Chief Scientific Officer · 10b5-1

$166.0K

1.0K sh · $166.00 avg · 5 lots

Own -8%
BLTE Sell·S
Apr 20, 26

Chief Scientific Officer · 10b5-1

$163.6K

1.0K sh · $163.59 avg · 7 lots

Own -7%
BLTE Sell·S
Apr 17, 26

Chief Scientific Officer · 10b5-1

$161.6K

1.0K sh · $161.63 avg · 6 lots

Own -7%
BLTE Sell·S
Apr 16, 26

Chief Scientific Officer · 10b5-1

$160.4K

1.0K sh · $160.38 avg · 7 lots

Own -6%
BLTE Sell·S
Apr 15, 26

Chief Scientific Officer · 10b5-1

$168.3K

1.0K sh · $168.30 avg · 5 lots

Own -6%
BLTE Grant·A
Mar 31, 26

Chief Scientific Officer

$0

144.9K sh

Own +118%

Date▾	Ticker	Role	Type	Shares	Own Δ	Price	Value
May 7, 2026	BLTE	Chief Scientific Officer	Sell S	6664 lots	-100%	$153.21 avg	$102.0K
May 6, 2026	BLTE	Chief Scientific Officer	Sell S	1.0K6 lots	-60%	$153.84 avg	$153.8K
May 5, 2026	BLTE	Chief Scientific Officer	Sell S	1.0K6 lots	-38%	$155.50 avg	$155.5K
May 4, 2026	BLTE	Chief Scientific Officer	Sell S	1.0K5 lots	-27%	$155.64 avg	$155.6K
May 1, 2026	BLTE	Chief Scientific Officer	Sell S	1.0K8 lots	-21%	$155.78 avg	$155.8K
Apr 30, 2026	BLTE	Chief Scientific Officer	Sell S	1.0K4 lots	-18%	$156.97 avg	$157.0K
Apr 29, 2026	BLTE	Chief Scientific Officer	Sell S	1.0K5 lots	-15%	$155.82 avg	$155.8K
Apr 28, 2026	BLTE	Chief Scientific Officer	Sell S	1.0K9 lots	-13%	$159.16 avg	$159.2K
Apr 27, 2026	BLTE	Chief Scientific Officer	Sell S	1.0K5 lots	-12%	$162.64 avg	$162.6K
Apr 24, 2026	BLTE	Chief Scientific Officer	Sell S	1.0K6 lots	-10%	$159.56 avg	$159.6K
Apr 23, 2026	BLTE	Chief Scientific Officer	Sell S	1.0K6 lots	-9%	$166.28 avg	$166.3K
Apr 22, 2026	BLTE	Chief Scientific Officer	Sell S	1.0K9 lots	-9%	$170.38 avg	$170.4K
Apr 21, 2026	BLTE	Chief Scientific Officer	Sell S	1.0K5 lots	-8%	$166.00 avg	$166.0K
Apr 20, 2026	BLTE	Chief Scientific Officer	Sell S	1.0K7 lots	-7%	$163.59 avg	$163.6K
Apr 17, 2026	BLTE	Chief Scientific Officer	Sell S	1.0K6 lots	-7%	$161.63 avg	$161.6K
Apr 16, 2026	BLTE	Chief Scientific Officer	Sell S	1.0K7 lots	-6%	$160.38 avg	$160.4K
Apr 15, 2026	BLTE	Chief Scientific Officer	Sell S	1.0K5 lots	-6%	$168.30 avg	$168.3K
Mar 31, 2026	BLTE	Chief Scientific Officer	Grant A	144.9K	+118%	—	$0

Buy Sell Non-market (grant · exercise · gift)

About Nathan L. Mata

This profile aggregates every SEC Form 4 insider transaction reported by Nathan L. Mata across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.